Patent Pooling in Public Health

Burrone, Esteban

doi:10.1017/9781316809587.008

The Cambridge Handbook of Public-Private Partnerships, Intellectual Property Governance, and Sustainable Development

DOI: 10.1017/9781316809587.008

|View full text |Cite

Patent Pooling in Public Health

Esteban Burrone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly

Florio

Gamba

2021

Ann Public Coop Econ

View full text Add to dashboard Cite

After a brief analysis of the causes underlying the failure of both governments and the pharma industry in terms of preparedness for the COVID‐19 pandemic, and after a discussion of further risks of health emergencies in the coming decades, this paper proposes a new public policy approach. The proposal aims at a major European initiative for the provision of research and development (R&D) in the biomedical field, based on public health priorities. A plan is discussed for an international, interconnected, transparent, science‐informed and publicly funded research infrastructure for pharmaceutical and biomedical research combined with a public enterprise: Biomed Europa. The proposed platform aims to identify research priorities in the public health sector, focusing its efforts on the development of preventive and therapeutic strategies against those diseases that will pose the greatest threats to human and social welfare over future decades. Biomed Europa could be managed as both an international research infrastructure, along the model of CERN, or the EMBL (European Molecular Biology Laboratory, Heidelberg) and as a knowledge‐intensive public enterprise with an industrial policy mission, such as the ESA (European Space Agency).

show abstract

Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly

Florio

Gamba

2021

Ann Public Coop Econ

View full text Add to dashboard Cite

show abstract

Patent pooling to increase access to essential medicines

Burrone

Gotham

Gray

et al. 2019

Bull. World Health Organ.

Self Cite

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Patent Pooling in Public Health

Cited by 2 publications

References 3 publications

Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly

Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly

Patent pooling to increase access to essential medicines

Contact Info

Product

Resources

About